New Publications:

Skurnik et al. (2012). Targeting Pan-Resistant Bacteria With Antibodies to a Broadly Conserved Surface Polysaccharide Expressed During Infection. J Infect Dis (Epub 2012 Apr 25]. PMID: 22448004; PMC Journal - In Process.

Ymele-Leki P, Cao S, Sharp J, Lambert KG, McAdam AJ, Husson RN, Tamayo G, Clardy J, Watnick PI (2012). A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity. PLoS One 7(2):e31307. PMID: 22359585; PMCID: PMC3281070.

Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P, Ayllon J, Palese P, Shaw ML (2012). A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. PLoS Pathog 8(4): e1002668.

Barczak AK, Gomez JE, Kaufmann BB, Hinson ER, Cosimi L, Borowsky ML, Onderdonk AB, Stanley SA, Kaur D, Bryant KF, Knipe DM, Sloutsky A, Hung DT (2012). RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities. Proc Natl Acad Sci U S A 109(16): 6217-22. PMID: 22474362; PMC Journal - In Process .

Events:

Medicinal Chemistry and Preclinical Development Workshop
September 21, 2012 Boston, MA

Funding Opportunities:

RFA-AI-12-017: Partnerships for Development of Therapeutics and Diagnostics for Biodefense (R01)

RFA-AI-12-014: Partnership for Development of Vaccine Technologies (R01)